The developing fetus can potentially be affected by any medication given to the mother. The disastrous effects of thalidomide and stilbestrol on the exposed offspring led to the development of the U.S. Food and Drug Administration (FDA) categories that are now assigned before a drug is released.
Table B-l lists safe treatments for dermatologic diseases in pregnancy, and the common dermatologic diseases, the drugs used for them, and the drugs’ pregnancy categories are listed in Table B-2.
TABLE B-1 SAFE TREATMENTS FOR DERMATOLOGIC DISORDERS DURING PREGNANCY
TABLE B-2 COMMON DERMATOLOGIC DISEASES, DRUGS USED, AND THEIR PREGNANCY CATEGORIES
